©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Transplant. Jun 28, 2018; 8(3): 68-74
Published online Jun 28, 2018. doi: 10.5500/wjt.v8.i3.68
Published online Jun 28, 2018. doi: 10.5500/wjt.v8.i3.68
Vaccination practices in End Stage Renal Failure and Renal Transplantation; Review of current guidelines and recommendations
Nalaka Gunawansa, National Institute of Nephrology Dialysis and Transplantation, Sri Lanka and Faculty of Health and Science, Institute of Learning and Teaching, University of Liverpool, Liverpool 111, United Kingdom
Roshni Rathore, Department of Renal, University Hospitals of Coventry and Warwickshire and Faculty of Health and Science, Institute of Learning and Teaching, University of Liverpool, Liverpool 111, United Kingdom
Ajay Sharma, Ahmed Halawa, Faculty of Health and Science, Institute of Learning and Teaching, University of Liverpool and Royal Liverpool University Hospital, Liverpool 111, United Kingdom
Conflict-of-interest statement: No potential conflicts of interest relevant to this article were reported.
Correspondence to: Nalaka Gunawansa, MBBS, MD, MS, MCh, FCSSL, Vascular and Transplant Surgeon, National Institute of Nephrology Dialysis and Transplantation, Sri Lanka and Faculty of Health and Science, Institute of Learning and Teaching, University of Liverpool, Liverpool 111, United Kingdom. vascular@drnalakagunawansa.com
Telephone: +44-94-773737644
Received: November 24, 2017
Peer-review started: November 24, 2017
First decision: January 6, 2018
Revised: February 2, 2018
Accepted: March 13, 2018
Article in press: March 13, 2018
Published online: June 28, 2018
Processing time: 214 Days and 19.7 Hours
Peer-review started: November 24, 2017
First decision: January 6, 2018
Revised: February 2, 2018
Accepted: March 13, 2018
Article in press: March 13, 2018
Published online: June 28, 2018
Processing time: 214 Days and 19.7 Hours
Core Tip
Core tip: Patients in end-stage renal failure and those after renal transplantation have a higher risk of opportunistic infections with catastrophic complications and poor response to standard vaccines. Special individualized consideration is needed to immunize these patients within the existing vaccination protocols.